Growth HormoneCJC-1295 WITH DAC
10MG
$120
Description
CJC-1295 with Drug Affinity Complex (DAC) is a modified growth hormone-releasing hormone (GHRH) analog with an extended half-life of approximately 6-8 days, compared to minutes for natural GHRH. The DAC modification allows CJC-1295 to bind to albumin in the bloodstream, dramatically extending its duration of action and providing sustained, elevated growth hormone and IGF-1 levels. This creates a steady, consistent elevation in GH rather than the sharp pulsatile release seen with non-DAC versions, making it ideal for research into sustained GH elevation effects.
Potential Benefits
Research Notes
Research published in the Journal of Clinical Endocrinology & Metabolism showed that a single injection of CJC-1295 DAC resulted in sustained elevation of GH levels for up to 6 days and IGF-1 levels for up to 11 days, with mean IGF-1 levels increasing by 1.5 to 3-fold. The DAC bioconjugation technology prevents enzymatic degradation and renal clearance, representing a significant advancement in peptide pharmacokinetics.
Usage Information
For research and educational purposes only. Consult with a qualified professional before use.
All peptides must be refrigerated upon receipt.
RESEARCH PURPOSES ONLY
This product is intended for research and educational purposes only. Not intended for human consumption. Not intended to diagnose, treat, cure, or prevent any disease.